Bone Loss Men

Featured Article

This is a study to assess if men with metastatic prostate cancer who are undergoing androgen deprivation treatments respond to the experimental med dasatinib. Bone-loss markers will be assessed during the trial. This international study is currently recruiting patients.

Read more

More information on "Bone Loss Men"

From Our Experts

See more SharePosts »

From Our Sources

More on Osteoporosis »